Tempus AI (NASDAQ:TEM) CEO Eric Lefkofsky Sells 332,500 Shares

Key Points

• Tempus AI CEO Eric Lefkofsky sold 332,500 shares of the company’s stock for a total of $24.64 million, reducing his holdings by 3.49% to approximately 9.21 million shares.
• The company reported a quarterly revenue of $314.64 million, exceeding analyst estimates and reflecting an 89.5% increase compared to the previous year.
• Analysts have mixed ratings for Tempus AI, with a consensus average target price of $67.64, indicating a potential for growth following a strong quarter.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric Lefkofsky sold 332,500 shares of the company's stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the sale, the chief executive officer owned 9,207,533 shares in the company, valued at approximately $682,278,195.30. This represents a 3.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Tempus AI Price Performance

TEM stock traded up $2.20 during midday trading on Friday, reaching $75.86. The stock had a trading volume of 7,646,161 shares, compared to its average volume of 12,480,006. The company's fifty day simple moving average is $64.16 and its 200 day simple moving average is $59.41. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The company has a market cap of $13.18 billion, a price-to-earnings ratio of -63.75 and a beta of 4.98. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company's quarterly revenue was up 89.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Concord Wealth Partners raised its position in shares of Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after buying an additional 308 shares during the last quarter. Allworth Financial LP lifted its stake in shares of Tempus AI by 5,000.0% in the 2nd quarter. Allworth Financial LP now owns 459 shares of the company's stock valued at $29,000 after purchasing an additional 450 shares in the last quarter. Cherry Tree Wealth Management LLC acquired a new position in Tempus AI during the 1st quarter worth approximately $31,000. SouthState Corp lifted its position in Tempus AI by 3,761.5% during the 2nd quarter. SouthState Corp now owns 502 shares of the company's stock worth $32,000 after acquiring an additional 489 shares in the last quarter. Finally, University of Texas Texas AM Investment Management Co. purchased a new position in Tempus AI in the 1st quarter worth approximately $33,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Wall Street Analysts Forecast Growth

TEM has been the topic of several research analyst reports. Morgan Stanley boosted their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a report on Tuesday, August 12th. Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Bank of America increased their price objective on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. BTIG Research upped their price target on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research note on Wednesday, August 20th. Finally, Needham & Company LLC restated a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $67.64.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.